| Results summary | View all lists in L2L MDB | View all genes in S01ED.profile.u50 |
|
Upregulated in samples of gastric cancer refractory to 5-FU/cisplatin treatment, compared to chemosensitive controls enrichment: 3.97-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 203685_AT | BCL2 | G | T | X | S | B-cell CLL/lymphoma 2 | |||||||
| 210528_AT | MR1 | X | major histocompatibility complex, class I-related | ||||||||||